264 related articles for article (PubMed ID: 2479237)
21. Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.
Bogdanowicz JF; Bentvelsen FM; Oosterom R; Schroeder FH
Scand J Urol Nephrol Suppl; 1991; 138():97-103. PubMed ID: 1723815
[TBL] [Abstract][Full Text] [Related]
22. [Benign prostatic hypertrophy with high levels of gamma-seminoprotein (gamma-Sm), prostate specific antigen: report of two cases].
Asakawa M; Yasumoto R; Kamizuru M; Maekawa M
Hinyokika Kiyo; 1988 Dec; 34(12):2189-91. PubMed ID: 2467544
[TBL] [Abstract][Full Text] [Related]
23. [Changes in prostatic acid phosphatase, gamma-seminoprotein and prostate specific antigen after endocrine therapy for stage D2 prostate cancer].
Akimoto S; Akakura K; Masai M; Isaka S; Shimazaki J
Hinyokika Kiyo; 1990 Jul; 36(7):783-91. PubMed ID: 1700588
[TBL] [Abstract][Full Text] [Related]
24. [Relationship between reactivation and tumor markers in prostatic cancer].
Fuse H; Umeda K; Kazama T; Sakamoto M; Sakai T; Fujishiro Y; Mizuno I; Katayama T
Hinyokika Kiyo; 1991 Jan; 37(1):39-43. PubMed ID: 1707217
[TBL] [Abstract][Full Text] [Related]
25. Multiple marker evaluation in prostatic cancer with prostatic acid phosphatase, gamma-seminoprotein and prostate-specific antigen.
Fuse H; Umeda K; Mizuno I; Katayama T
Int Urol Nephrol; 1991; 23(5):455-63. PubMed ID: 1718922
[TBL] [Abstract][Full Text] [Related]
26. Two prostate-specific antigens, gamma-seminoprotein and beta-microseminoprotein.
Hara M; Kimura H
J Lab Clin Med; 1989 May; 113(5):541-8. PubMed ID: 2654306
[TBL] [Abstract][Full Text] [Related]
27. [Measurement of serum prostatic acid phosphatase (PAP) by Delfia PAP Kit using europium and clinical evaluation in patients with prostate cancer].
Akimoto S; Ohki T; Ichikawa T; Akakura K; Shimazaki J
Hinyokika Kiyo; 1994 Nov; 40(11):987-93. PubMed ID: 7530404
[TBL] [Abstract][Full Text] [Related]
28. Relative reliability of five serially measured markers for prognosis of progression in prostate cancer.
Killian CS; Emrich LJ; Vargas FP; Yang N; Wang MC; Priore RL; Murphy GP; Chu TM
J Natl Cancer Inst; 1986 Feb; 76(2):179-85. PubMed ID: 2418245
[TBL] [Abstract][Full Text] [Related]
29. [Value of serum PSA and PAP measurement with newly developed latex turbidimetric immunoassay].
Akino H; Tsuka H; Okada K; Tsuchiya Y; Matsubara M; Arimura K
Hinyokika Kiyo; 1995 Jun; 41(6):439-45. PubMed ID: 7544063
[TBL] [Abstract][Full Text] [Related]
30. [A comparison between prostate-acid-phosphatase and prostate-specific antigen in the diagnosis of prostatic carcinoma].
Bentvelsen FM; Bogdanowicz JF; Oosterom R; Schröder FH
Ned Tijdschr Geneeskd; 1990 Aug; 134(33):1596-600. PubMed ID: 1697651
[TBL] [Abstract][Full Text] [Related]
31. [Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate].
Morote Robles J; de Torres Mateos JA
Arch Esp Urol; 1989; 42 Suppl 2():124-30. PubMed ID: 2484148
[TBL] [Abstract][Full Text] [Related]
32. [gamma-Seminoprotein in serum of prostatic cancer].
Fuse H; Masukagami T; Kataumi Z; Shimazaki J
Hinyokika Kiyo; 1985 Jan; 31(1):81-5. PubMed ID: 3993497
[TBL] [Abstract][Full Text] [Related]
33. [Tumor markers of prostate cancer--evaluation of serum PAP and PA].
Miki M
Gan No Rinsho; 1985 May; 31(6 Suppl):664-9. PubMed ID: 2411965
[TBL] [Abstract][Full Text] [Related]
34. The value of prostatic acid phosphatase and prostate specific antigen as serum markers in carcinoma of the prostate.
Akdaş A; Simşek F; Ilker Y; Türkeri L; Ercan H
Int Urol Nephrol; 1993; 25(3):271-8. PubMed ID: 7693607
[TBL] [Abstract][Full Text] [Related]
35. [Tumor markers in prostate cancer].
Kuriyama M
Gan To Kagaku Ryoho; 1994 Sep; 21(12):1915-22. PubMed ID: 7521999
[TBL] [Abstract][Full Text] [Related]
36. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.
Stamey TA; Yang N; Hay AR; McNeal JE; Freiha FS; Redwine E
N Engl J Med; 1987 Oct; 317(15):909-16. PubMed ID: 2442609
[TBL] [Abstract][Full Text] [Related]
37. [Value of prostate-specific antigen measurements with newly developed enzyme immunoassay (MARKIT-M PA)].
Arai Y; Onishi H; Oishi K; Takeuchi H; Yoshida O
Hinyokika Kiyo; 1992 Oct; 38(10):1129-34. PubMed ID: 1282772
[TBL] [Abstract][Full Text] [Related]
38. [Prostatic acid phosphatase and prostatic specific antigen measured by immunoenzyme assay].
Fuse H; Akimoto S; Shimazaki J
Hinyokika Kiyo; 1986 Dec; 32(12):1813-9. PubMed ID: 2435130
[TBL] [Abstract][Full Text] [Related]
39. [Clinical evaluation of a new kit (IMX PA Dainapack) for detection of serum prostate specific antigen].
Machida T; Ohishi Y; Wada T; Akimoto S; Shimazaki J; Oda H; Yokoyama M; Tsukada T; Nakayama T; Akiyama A
Hinyokika Kiyo; 1993 Oct; 39(10):977-84. PubMed ID: 7505519
[TBL] [Abstract][Full Text] [Related]
40. Serial measurements of tissue polypeptide specific antigen (TPS), PSA, PAP and CEA serotest values in treated patients with primary and metastatic prostate cancer.
Tarle M
Anticancer Res; 1993; 13(3):769-77. PubMed ID: 7686362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
